171 related articles for article (PubMed ID: 23599765)
1. Abnormal methylation of seven genes and their associations with clinical characteristics in early stage non-small cell lung cancer.
Zhao Y; Zhou H; Ma K; Sun J; Feng X; Geng J; Gu J; Wang W; Zhang H; He Y; Guo S; Zhou X; Yu J; Lin Q
Oncol Lett; 2013 Apr; 5(4):1211-1218. PubMed ID: 23599765
[TBL] [Abstract][Full Text] [Related]
2. DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type.
Hawes SE; Stern JE; Feng Q; Wiens LW; Rasey JS; Lu H; Kiviat NB; Vesselle H
Lung Cancer; 2010 Aug; 69(2):172-9. PubMed ID: 19945765
[TBL] [Abstract][Full Text] [Related]
3. Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.
Walter RFH; Rozynek P; Casjens S; Werner R; Mairinger FD; Speel EJM; Zur Hausen A; Meier S; Wohlschlaeger J; Theegarten D; Behrens T; Schmid KW; Brüning T; Johnen G
PLoS One; 2018; 13(5):e0195716. PubMed ID: 29851970
[TBL] [Abstract][Full Text] [Related]
4. Application of GLAD-PCR Assay for Study on DNA Methylation in Regulatory Regions of Some Tumor-Suppressor Genes in Lung Cancer.
Smetannikova NA; Evdokimov AA; Netesova NA; Abdurashitov MA; Akishev AG; Dubinin EV; Pozdnyakov PI; Vihlyanov IV; Nikitin MK; Topolnitsky EB; Karpov AB; Kolomiets SA; Degtyarev SK
Zhongguo Fei Ai Za Zhi; 2019 Sep; 22(9):551-561. PubMed ID: 31526458
[TBL] [Abstract][Full Text] [Related]
5. RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China.
Lin Q; Geng J; Ma K; Yu J; Sun J; Shen Z; Bao G; Chen Y; Zhang H; He Y; Luo X; Feng X; Zhu J
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1675-84. PubMed ID: 19506903
[TBL] [Abstract][Full Text] [Related]
6. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.
Zhang Y; Wang R; Song H; Huang G; Yi J; Zheng Y; Wang J; Chen L
Cancer Lett; 2011 Apr; 303(1):21-8. PubMed ID: 21255913
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of SOX1 promotes cell migration in lung cancer.
Li N; Li S
Tumour Biol; 2015 Jun; 36(6):4603-10. PubMed ID: 25613070
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
[TBL] [Abstract][Full Text] [Related]
9. Concomitant hypermethylation of multiple genes in non-small cell lung cancer (NSCLC).
Ji M; Guan H; Shi B; Hou P
Folia Histochem Cytobiol; 2011; 49(1):132-41. PubMed ID: 21526500
[TBL] [Abstract][Full Text] [Related]
10. [Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells].
Fang HL; Yu ZC; Zhu HB; Jin YT
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):658-63. PubMed ID: 23159077
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients.
Feng Q; Hawes SE; Stern JE; Wiens L; Lu H; Dong ZM; Jordan CD; Kiviat NB; Vesselle H
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):645-54. PubMed ID: 18349282
[TBL] [Abstract][Full Text] [Related]
12. DNA hypermethylated status and gene expression of
Huang J; Tan ZR; Yu J; Li H; Lv QL; Shao YY; Zhou HH
Onco Targets Ther; 2017; 10():4739-4751. PubMed ID: 29033587
[TBL] [Abstract][Full Text] [Related]
13. [DNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancer].
Song H; Yi J; Zhang Y; Wang R; Chen L
Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):233-8. PubMed ID: 21426665
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-induced downregulation of SOX1 increases drug resistance by activating autophagy in non-small cell lung cancer cell.
Li N; Li X; Li S; Zhou S; Zhou Q
Biochem Biophys Res Commun; 2013 Sep; 439(2):187-90. PubMed ID: 23994634
[TBL] [Abstract][Full Text] [Related]
15. [Expression of hUTP14a in non-small cell lung cancer].
Zhang CF; Liu Y; Lu M; DU XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 51(1):145-150. PubMed ID: 30773559
[TBL] [Abstract][Full Text] [Related]
16. DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer.
Wang Z; Chen Z; Gao Y; Li N; Li B; Tan F; Tan X; Lu N; Sun Y; Sun J; Sun N; He J
Cancer Biol Ther; 2011 Mar; 11(5):490-6. PubMed ID: 21383543
[TBL] [Abstract][Full Text] [Related]
17. CHFR hypermethylation and EGFR mutation are mutually exclusive and exhibit contrastive clinical backgrounds and outcomes in non-small cell lung cancer.
Koga T; Takeshita M; Yano T; Maehara Y; Sueishi K
Int J Cancer; 2011 Mar; 128(5):1009-17. PubMed ID: 20473935
[TBL] [Abstract][Full Text] [Related]
18. Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma.
Tang L; Liou YL; Wan ZR; Tang J; Zhou Y; Zhuang W; Wang G
Biomed Pharmacother; 2019 Dec; 120():109488. PubMed ID: 31629253
[TBL] [Abstract][Full Text] [Related]
19. Detection of SHOX2 DNA methylation by methylation-specific PCR in non-small cell lung cancer.
Feng H; Shao W; Du L; Qing X; Zhang Z; Liang C; Liu D
Transl Cancer Res; 2020 Oct; 9(10):6070-6077. PubMed ID: 35117218
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian patients.
Haroun RA; Zakhary NI; Mohamed MR; Abdelrahman AM; Kandil EI; Shalaby KA
Asian Pac J Cancer Prev; 2014; 15(10):4281-7. PubMed ID: 24935385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
